v3 Template
V

Vandria SA

Biotechnology / Healthcare ~580 employees
Founded
--
Employees (Est.)
~580
29 leaders known
Total Funding
$55.4M
Funding Rounds
3
Last Funding
2024-08-21

About Vandria SA

Vandria is a company focused on developing best-in-class mitophagy inducers to rejuvenate cells and treat age-related and chronic diseases, positioning itself at the forefront of mitochondrial therapeutics.

Products & Services

Mitophagy Inducers:Therapeutics designed to rejuvenate cells for treating age-related and chronic diseases.

Specialties

Mitochondrial Therapeutics Mitophagy Induction Age-Related Disease Treatment Chronic Disease Treatment

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series A
T: -
FT: Series A 		A: 30700000
MR: -
FA: $30.7M
FAN: 30700000 		D: 2024-08-21
FD: 2024-08-21 		3 investors
2 RT: Grant
T: -
FT: Grant 		A: 4104000
MR: -
FA: €3.8M
FAN: 4104000 		D: 2024-02-08
FD: 2024-02-08 		2 investors
3 RT: Series A
T: -
FT: Series A 		A: 20600000
MR: -
FA: $20.6M (CHF18M)
FAN: 20600000 		D: 2023-12-14
FD: 2023-12-14 		2 investors
Series A Latest
2024-08-21
$30.7M
3 investors (Pro only)
Grant 2024-02-08
$4.1M
Series A 2023-12-14
$20.6M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

K

Klaus Dugi

Director Preclinical Operations

LinkedIn (Pro only)
P

Pénélope Andreux

CEO & Board Member

LinkedIn (Pro only)
P

Peter Harboe-Schmidt

Chief Scientific Officer

LinkedIn (Pro only)
P

Patrick Aebischer

Chairman

C

Chris Rinsch

Chairman

J

Jens Eckstein

Chairman

View 26 more team members with Pro

Unlock Full Team Directory

Recent News

Vandria SA Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Healthcare
Company Size
~580 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro